Clinical Trial Update: Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration [NA]

View source ↗

Summary

This document describes a post-market clinical investigation of the SING IMT System (Model NG SI IMT 3X) for end-stage age-related macular degeneration, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• SING IMT System, Model NG SI IMT 3X

Snippet

Sponsor: VisionCare, Inc. | Conditions: AMD, Age-Related Macular Degeneration | NA | Status: RECRUITING